Comparison between Earum Pharmaceuticals IPO and Wonder Fibromats IPO.
IPO Details
Earum Pharmaceuticals IPO is a SME Fixed Price IPO proposed to list at BSE SME while Wonder Fibromats IPO is a SME Fixed Price proposed to list at NSE SME.
Issue Size and Price
The total issue size of Earum Pharmaceuticals IPO is up to ₹6.31 Cr whereas the issue size of the Wonder Fibromats IPO is up to ₹18.80 Cr. The final issue price of Earum Pharmaceuticals IPO is ₹36.00 per share and of Wonder Fibromats IPO is ₹89.00 per share.
IPO Timetable
Earum Pharmaceuticals IPO opens on Jun 21, 2019, while Wonder Fibromats IPO opens on Jul 22, 2019. The closing date of Earum Pharmaceuticals IPO and Wonder Fibromats IPO is Jun 26, 2019, and Jul 29, 2019, respectively.
| | Earum Pharmaceuticals IPO | Wonder Fibromats IPO |
|---|
| Issue Open | Jun 21, 2019 | Jul 22, 2019 |
| Issue Close | Jun 26, 2019 | Jul 29, 2019 |
| Basis Of Allotment (Tentative) | Jul 01, 2019 | Jul 29, 2019 |
| Initiation of Refunds (Tentative) | Jul 02, 2019 | Jul 30, 2019 |
| Credit of Share (Tentative) | Jul 03, 2019 | Jul 31, 2019 |
| Listing date (Tentative) | Jul 04, 2019 | Aug 06, 2019 |
Financials & KPIs
Earum Pharmaceuticals IPO P/E ratio is , as compared to Wonder Fibromats IPO P/E ratio of .
Shares Offered
In the Earum Pharmaceuticals IPO Retail Individual Investors (RII) are offered 8,76,000 shares while in Wonder Fibromats IPO retail investors are offered 8,76,000 shares. Qualified Institutional Buyers (QIB) are offered in Earum Pharmaceuticals IPO and in Wonder Fibromats IPO.
| | Earum Pharmaceuticals IPO | Wonder Fibromats IPO |
|---|
| Market Maker Reservation | 96,000 shares | 1,12,000 shares |
| NII | 8,76,000 shares | 10,56,000 shares |
| RII | 8,76,000 shares | 10,56,000 shares |
| Total | 17,52,000 shares | 21,12,000 shares |
Bids Received (Subscription)
Earum Pharmaceuticals IPO subscribed 1.60x in total, whereas Wonder Fibromats IPO subscribed 1.26x.
